The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-prop-2-enamide ID: ALA5183924
PubChem CID: 137376693
Max Phase: Preclinical
Molecular Formula: C25H21FN8O3
Molecular Weight: 500.49
Associated Items:
Names and Identifiers Canonical SMILES: C=C(F)C(=O)Nc1cc2c(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)ncnc2cc1OCC
Standard InChI: InChI=1S/C25H21FN8O3/c1-4-36-21-9-18-17(8-19(21)32-25(35)15(3)26)24(28-11-27-18)31-16-5-6-20(14(2)7-16)37-23-10-22-33-30-13-34(22)12-29-23/h5-13H,3-4H2,1-2H3,(H,32,35)(H,27,28,31)
Standard InChI Key: ZYLWPLCMORTKOJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
-2.4474 -0.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7328 -0.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0209 -0.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0209 -1.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7310 -1.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4474 -1.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3082 -0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4066 -0.6168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4084 -1.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3031 -1.8545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3082 0.6208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4063 1.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4065 1.8586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1194 2.2693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8342 1.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8358 1.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1240 0.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1194 3.0945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5489 2.2692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2635 1.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9781 2.2692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6928 1.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6928 1.0314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9781 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2635 1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1497 -0.1882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3060 0.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9703 -0.2745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1621 -0.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8766 -0.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5913 -0.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8766 -1.4408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3060 -0.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1621 -1.8567 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1621 -2.6819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8766 -3.0945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5913 0.6221 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
14 18 1 0
15 19 1 0
19 20 1 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 1 0
25 24 1 0
20 25 2 0
24 26 2 0
23 27 1 0
27 28 2 0
28 26 1 0
1 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
31 33 2 0
6 34 1 0
34 35 1 0
35 36 1 0
31 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 500.49Molecular Weight (Monoisotopic): 500.1721AlogP: 4.73#Rotatable Bonds: 8Polar Surface Area: 128.45Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.93CX Basic pKa: 4.93CX LogP: 2.82CX LogD: 2.82Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.29Np Likeness Score: -1.57
References 1. Li D, Tu Y, Jin K, Duan L, Hong Y, Xu J, Chen N, Zhang Z, Zuo H, Gong W, Zhang J, Wang Q, Qian H, Wang X, Ke Y, Xia G.. (2022) Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment., 65 (7.0): [PMID:35319895 ] [10.1021/acs.jmedchem.1c00710 ]